This article is long. However, to make it worth revisiting, I have provided three guideposts. Guidepost 1: Confidence Labels ...
Recursion Pharmaceuticals is maintained at a "Hold" rating, pending further regulatory clarity and late-stage trial ...
Extracting from structure rather than generating informationThe amount of information on the internet continues to grow.Social media posts, news articles, user reports, source code, and vast amounts ...
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Membership today. It is, perhaps, the ultimate promise of artificial intelligence: AI systems ...
How do you get from a chatbot that sometimes makes things up to a machine that humans might struggle to control? There are several steps in that argument, and plenty of uncertainty. But an idea known ...
Anthropic and OpenAI researchers raised fresh concerns about recursive self-improvement, the process by which AI helps improve the development of models. Both OpenAI and Anthropic have in recent ...
AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...
Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...
Relation Insurance Services announced their acquisition of the assets of Mid-State Insurance. The transaction went into effect on March 31, 2026; terms of the transaction were not disclosed. Founded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results